Prokidney: Clinical Trials

2 trials sponsored by Prokidney, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 withdrawn. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Active not recruiting 1, Withdrawn 1

Follow Prokidney: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney Disease
Renal Autologous Cell Therapy (REACT), Sham Comparator - Type 2 Diabetes Mellitus, Chronic Kidney Diseases
Phase 3WithdrawnProkidney2024-07-172024-09-25
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Renal Autologous Cell Therapy (REACT/ rilparencel), Sham Comparator - Type 2 Diabetes Mellitus, Chronic Kidney Diseases
Phase 3Active not recruitingProkidney6852022-01-052026-08-11

Conditions studied

Diabetes Mellitus, Type 2 (2)  ·  Renal Insufficiency, Chronic (2)

Countries

Mexico (1)  ·  Puerto Rico (1)  ·  Spain (1)  ·  Taiwan (1)  ·  United States (1)

Results publications

PMID 40333016, PMID 41481370